The antiangiogenic/tumor suppressive activity of miR-101 was confirmed by in vivo experiments in xenograft models of cholangiocarcinoma showing that overexpression of this miRNA in CCLP1 and HuCCT1 cell lines markedly inhibited tumor growth and progression [120]. This evidence concerns the gene PPFIBP2 and neoplasm.